Literature DB >> 32515814

Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults.

Benjamin M Smith1,2, Miranda Kirby3, Eric A Hoffman4,5,6, Richard A Kronmal7, Shawn D Aaron8, Norrina B Allen9, Alain Bertoni10, Harvey O Coxson11, Chris Cooper12, David J Couper13, Gerard Criner14, Mark T Dransfield15, MeiLan K Han16, Nadia N Hansel17, David R Jacobs18, Joel D Kaufman19,20, Ching-Long Lin21, Ani Manichaikul22, Fernando J Martinez23, Erin D Michos17, Elizabeth C Oelsner1, Robert Paine24, Karol E Watson12, Andrea Benedetti2, Wan C Tan25, Jean Bourbeau2, Prescott G Woodruff26, R Graham Barr1.   

Abstract

Importance: Smoking is a major risk factor for chronic obstructive pulmonary disease (COPD), yet much of COPD risk remains unexplained. Objective: To determine whether dysanapsis, a mismatch of airway tree caliber to lung size, assessed by computed tomography (CT), is associated with incident COPD among older adults and lung function decline in COPD. Design, Setting, and Participants: A retrospective cohort study of 2 community-based samples: the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study, which involved 2531 participants (6 US sites, 2010-2018) and the Canadian Cohort of Obstructive Lung Disease (CanCOLD), which involved 1272 participants (9 Canadian sites, 2010-2018), and a case-control study of COPD: the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS), which involved 2726 participants (12 US sites, 2011-2016). Exposures: Dysanapsis was quantified on CT as the geometric mean of airway lumen diameters measured at 19 standard anatomic locations divided by the cube root of lung volume (airway to lung ratio). Main Outcomes and Measures: Primary outcome was COPD defined by postbronchodilator ratio of forced expired volume in the first second to vital capacity (FEV1:FVC) less than 0.70 with respiratory symptoms. Secondary outcome was longitudinal lung function. All analyses were adjusted for demographics and standard COPD risk factors (primary and secondhand tobacco smoke exposures, occupational and environmental pollutants, and asthma).
Results: In the MESA Lung sample (mean [SD] age, 69 years [9 years]; 1334 women [52.7%]), 237 of 2531 participants (9.4%) had prevalent COPD, the mean (SD) airway to lung ratio was 0.033 (0.004), and the mean (SD) FEV1 decline was -33 mL/y (31 mL/y). Of 2294 MESA Lung participants without prevalent COPD, 98 (4.3%) had incident COPD at a median of 6.2 years. Compared with participants in the highest quartile of airway to lung ratio, those in the lowest had a significantly higher COPD incidence (9.8 vs 1.2 cases per 1000 person-years; rate ratio [RR], 8.12; 95% CI, 3.81 to 17.27; rate difference, 8.6 cases per 1000 person-years; 95% CI, 7.1 to 9.2; P < .001) but no significant difference in FEV1 decline (-31 vs -33 mL/y; difference, 2 mL/y; 95% CI, -2 to 5; P = .30). Among CanCOLD participants (mean [SD] age, 67 years [10 years]; 564 women [44.3%]), 113 of 752 (15.0%) had incident COPD at a median of 3.1 years and the mean (SD) FEV1 decline was -36 mL/y (75 mL/y). The COPD incidence in the lowest airway to lung quartile was significantly higher than in the highest quartile (80.6 vs 24.2 cases per 1000 person-years; RR, 3.33; 95% CI, 1.89 to 5.85; rate difference, 56.4 cases per 1000 person-years; 95% CI, 38.0 to 66.8; P<.001), but the FEV1 decline did not differ significantly (-34 vs -36 mL/y; difference, 1 mL/y; 95% CI, -15 to 16; P=.97). Among 1206 SPIROMICS participants (mean [SD] age, 65 years [8 years]; 542 women [44.9%]) with COPD who were followed up for a median 2.1 years, those in the lowest airway to lung ratio quartile had a mean FEV1 decline of -37 mL/y (15 mL/y), which did not differ significantly from the decline in MESA Lung participants (P = .98), whereas those in highest quartile had significantly faster decline than participants in MESA Lung (-55 mL/y [16 mL/y ]; difference, -17 mL/y; 95% CI, -32 to -3; P = .004). Conclusions and Relevance: Among older adults, dysanapsis was significantly associated with COPD, with lower airway tree caliber relative to lung size associated with greater COPD risk. Dysanapsis appears to be a risk factor associated with COPD.

Entities:  

Mesh:

Year:  2020        PMID: 32515814      PMCID: PMC7284296          DOI: 10.1001/jama.2020.6918

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  38 in total

1.  A structural approach to selection bias.

Authors:  Miguel A Hernán; Sonia Hernández-Díaz; James M Robins
Journal:  Epidemiology       Date:  2004-09       Impact factor: 4.822

2.  The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States.

Authors:  Ali H Mokdad; Katherine Ballestros; Michelle Echko; Scott Glenn; Helen E Olsen; Erin Mullany; Alex Lee; Abdur Rahman Khan; Alireza Ahmadi; Alize J Ferrari; Amir Kasaeian; Andrea Werdecker; Austin Carter; Ben Zipkin; Benn Sartorius; Berrin Serdar; Bryan L Sykes; Chris Troeger; Christina Fitzmaurice; Colin D Rehm; Damian Santomauro; Daniel Kim; Danny Colombara; David C Schwebel; Derrick Tsoi; Dhaval Kolte; Elaine Nsoesie; Emma Nichols; Eyal Oren; Fiona J Charlson; George C Patton; Gregory A Roth; H Dean Hosgood; Harvey A Whiteford; Hmwe Kyu; Holly E Erskine; Hsiang Huang; Ira Martopullo; Jasvinder A Singh; Jean B Nachega; Juan R Sanabria; Kaja Abbas; Kanyin Ong; Karen Tabb; Kristopher J Krohn; Leslie Cornaby; Louisa Degenhardt; Mark Moses; Maryam Farvid; Max Griswold; Michael Criqui; Michelle Bell; Minh Nguyen; Mitch Wallin; Mojde Mirarefin; Mostafa Qorbani; Mustafa Younis; Nancy Fullman; Patrick Liu; Paul Briant; Philimon Gona; Rasmus Havmoller; Ricky Leung; Ruth Kimokoti; Shahrzad Bazargan-Hejazi; Simon I Hay; Simon Yadgir; Stan Biryukov; Stein Emil Vollset; Tahiya Alam; Tahvi Frank; Talha Farid; Ted Miller; Theo Vos; Till Bärnighausen; Tsegaye Telwelde Gebrehiwot; Yuichiro Yano; Ziyad Al-Aly; Alem Mehari; Alexis Handal; Amit Kandel; Ben Anderson; Brian Biroscak; Dariush Mozaffarian; E Ray Dorsey; Eric L Ding; Eun-Kee Park; Gregory Wagner; Guoqing Hu; Honglei Chen; Jacob E Sunshine; Jagdish Khubchandani; Janet Leasher; Janni Leung; Joshua Salomon; Jurgen Unutzer; Leah Cahill; Leslie Cooper; Masako Horino; Michael Brauer; Nicholas Breitborde; Peter Hotez; Roman Topor-Madry; Samir Soneji; Saverio Stranges; Spencer James; Stephen Amrock; Sudha Jayaraman; Tejas Patel; Tomi Akinyemiju; Vegard Skirbekk; Yohannes Kinfu; Zulfiqar Bhutta; Jost B Jonas; Christopher J L Murray
Journal:  JAMA       Date:  2018-04-10       Impact factor: 56.272

Review 3.  Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease.

Authors:  Alvar Agustí; James C Hogg
Journal:  N Engl J Med       Date:  2019-09-26       Impact factor: 91.245

4.  Comparison of computed density and macroscopic morphometry in pulmonary emphysema.

Authors:  P A Gevenois; V de Maertelaer; P De Vuyst; J Zanen; J C Yernault
Journal:  Am J Respir Crit Care Med       Date:  1995-08       Impact factor: 21.405

5.  Smoking prevalence and cigarette consumption in 187 countries, 1980-2012.

Authors:  Marie Ng; Michael K Freeman; Thomas D Fleming; Margaret Robinson; Laura Dwyer-Lindgren; Blake Thomson; Alexandra Wollum; Ella Sanman; Sarah Wulf; Alan D Lopez; Christopher J L Murray; Emmanuela Gakidou
Journal:  JAMA       Date:  2014-01-08       Impact factor: 56.272

6.  Evidence for dysanapsis using computed tomographic imaging of the airways in older ex-smokers.

Authors:  A William Sheel; Jordan A Guenette; Ren Yuan; Lukas Holy; John R Mayo; Annette M McWilliams; Stephen Lam; Harvey O Coxson
Journal:  J Appl Physiol (1985)       Date:  2009-09-17

7.  Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.

Authors:  Miranda Kirby; Naoya Tanabe; Wan C Tan; Guohai Zhou; Ma'en Obeidat; Cameron J Hague; Jonathon Leipsic; Jean Bourbeau; Don D Sin; James C Hogg; Harvey O Coxson
Journal:  Am J Respir Crit Care Med       Date:  2018-01-01       Impact factor: 21.405

8.  Human airway branch variation and chronic obstructive pulmonary disease.

Authors:  Benjamin M Smith; Hussein Traboulsi; John H M Austin; Ani Manichaikul; Eric A Hoffman; Eugene R Bleecker; Wellington V Cardoso; Christopher Cooper; David J Couper; Stephen M Dashnaw; Jia Guo; MeiLan K Han; Nadia N Hansel; Emlyn W Hughes; David R Jacobs; Richard E Kanner; Joel D Kaufman; Eric Kleerup; Ching-Long Lin; Kiang Liu; Christian M Lo Cascio; Fernando J Martinez; Jennifer N Nguyen; Martin R Prince; Stephen Rennard; Stephen S Rich; Leora Simon; Yanping Sun; Karol E Watson; Prescott G Woodruff; Carolyn J Baglole; R Graham Barr
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-16       Impact factor: 11.205

9.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

10.  Development and first validation of the COPD Assessment Test.

Authors:  P W Jones; G Harding; P Berry; I Wiklund; W-H Chen; N Kline Leidy
Journal:  Eur Respir J       Date:  2009-09       Impact factor: 16.671

View more
  20 in total

Review 1.  Small Airway Disease in Pediatric Asthma: the Who, What, When, Where, Why, and How to Remediate. A Review and Commentary.

Authors:  Russell J Hopp; Mark C Wilson; M Asghar Pasha
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-26       Impact factor: 8.667

2.  Journal Club-Respiratory Impairment With A Preserved Spirometric Ratio.

Authors:  Takudzwa Mkorombindo; Ron Balkissoon
Journal:  Chronic Obstr Pulm Dis       Date:  2022-01-27

3.  COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry.

Authors:  Wilson D Pace; Elias Brandt; Victoria A Carter; Ku-Lang Chang; Chelsea L Edwards; Alexander Evans; Chester Fox; Gabriela Gaona; MeiLan K Han; Alan G Kaplan; Rachel Kent; Janwillem W H Kocks; Maja Kruszyk; Chantal E Le Lievre; Tessa Li Voti; Cathy Mahle; Barry Make; Amanda R Ratigan; Asif Shaikh; Neil Skolnik; Brooklyn Stanley; Barbara P Yawn; David B Price
Journal:  Ann Fam Med       Date:  2022 Jul-Aug       Impact factor: 5.707

4.  A computed tomography imaging-based subject-specific whole-lung deposition model.

Authors:  Xuan Zhang; Frank Li; Prathish K Rajaraman; Jiwoong Choi; Alejandro P Comellas; Eric A Hoffman; Benjamin M Smith; Ching-Long Lin
Journal:  Eur J Pharm Sci       Date:  2022-07-29       Impact factor: 5.112

5.  CT-Assessed Dysanapsis and Airflow Obstruction in Early and Mid Adulthood.

Authors:  Motahareh Vameghestahbanati; Grant T Hiura; R Graham Barr; Jessica C Sieren; Benjamin M Smith; Eric A Hoffman
Journal:  Chest       Date:  2021-08-12       Impact factor: 10.262

6.  Poor early childhood growth is associated with impaired lung function: Evidence from a Ghanaian pregnancy cohort.

Authors:  Seyram Kaali; Darby W Jack; Rebecca K D Prah; Steven N Chillrud; Mohammed N Mujtaba; Patrick L Kinney; Theresa Tawiah; Qiang Yang; Felix B Oppong; Carlos F Gould; Musah Osei; Blair J Wylie; Oscar Agyei; Matthew S Perzanowski; Kwaku Poku Asante; Alison G Lee
Journal:  Pediatr Pulmonol       Date:  2022-06-13

7.  Bronchopulmonary dysplasia as a determinant of respiratory outcomes in adult life.

Authors:  Joseph M Collaco; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2021-03-17

8.  Structural airway imaging metrics are differentially associated with persistent chronic bronchitis.

Authors:  Surya P Bhatt; Sandeep Bodduluri; Abhilash S Kizhakke Puliyakote; Elizabeth C Oelsner; Arie Nakhmani; David A Lynch; Carla G Wilson; Spyridon Fortis; Victor Kim
Journal:  Thorax       Date:  2021-01-06       Impact factor: 9.139

9.  Central Airway Tree Dysanapsis Extends to the Peripheral Airways.

Authors:  Motahareh Vameghestahbanati; Miranda Kirby; Naoya Tanabe; Dragoş M Vasilescu; Wim Janssens; Stephanie Everaerts; Bart M Vanaudenaerde; Andrea Benedetti; James C Hogg; Benjamin M Smith
Journal:  Am J Respir Crit Care Med       Date:  2021-02-01       Impact factor: 21.405

10.  Dysanapsis and the Spirometric Response to Inhaled Bronchodilators.

Authors:  Motahareh Vameghestahbanati; Miranda Kirby; François Maltais; Dennis Jensen; Dany Doiron; Wan C Tan; Jean Bourbeau; Benjamin M Smith
Journal:  Am J Respir Crit Care Med       Date:  2021-10-15       Impact factor: 30.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.